Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion [PDF]
: Secondary (functional) tricuspid regurgitation (sTR) is common in patients with mitral regurgitation (MR). Because combined valvular heart disease affects long-term survival, in comparison with isolated MR or tricuspid regurgitation, it is essential to
Maisano, Francesco +17 more
core +1 more source
Restoration of Life Expectancy After Transcatheter Edge-to-Edge Mitral Valve Repair [PDF]
BACKGROUND Survival data after mitral transcatheter edge-to-edge repair (TEER) are scarce, and its impact on predicted life expectancy is unknown.
Luigi Biasco +54 more
core +1 more source
Transesophageal Echocardiography for Mitral Valve Transcatheter Edge-to-Edge Repair
Transcatheter edge-to-edge repair (TEER) has emerged as a viable treatment option for patients with degenerative or functional severe mitral regurgitation (MR) who are at high risk for mitral valve surgery but have mitral valve anatomy suitable for TEER.
Nitin J Burkule, Manish Bansal
doaj +1 more source
Sex-Related Clinical Characteristics and Outcomes of Patients Undergoing Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation. [PDF]
OBJECTIVES The authors sought to assess sex-based differences in characteristics and outcomes of patients undergoing transcatheter edge-to-edge mitral valve repair (TMVR) for secondary mitral regurgitation (SMR).
Petrescu, Aniela +22 more
core +1 more source
Systematic Fluoroscopic-Echocardiographic Fusion Imaging Protocol for Transcatheter Edge-to-Edge Mitral Valve Repair Intraprocedural Monitoring. [PDF]
DOI: 10.1016/j.echo.2021.01.010 Fluoroscopic-echocardiographic fusion imaging (FI) is able to acquire imaging data from both fluoroscopy and transesophageal images and co-register and align them in the 3D space and time by putting onto the same ...
Agricola, Eustachio
core +1 more source
Transcatheter edge-to-edge repair for mitral regurgitation [PDF]
Mitral valve transcatheter edge-to-edge repair (M-TEER) has emerged as a transformative therapy for mitral regurgitation (MR), addressing the unmet needs of patients unsuitable for surgery. Landmark trials such as EVEREST II, COAPT, and MITRA-FR have established the safety and efficacy of M-TEER, in both patients with primary (PMR) and secondary MR ...
Philipp von Stein, Christos Iliadis
openaire +2 more sources
Background Limited data are available about clinical outcomes and residual mitral regurgitation (MR) after transcatheter edge‐to‐edge repair in the large Asian‐Pacific cohort.
Shunsuke Kubo +22 more
doaj +1 more source
1-Year Outcomes After Edge-to-Edge Valve Repair for Symptomatic Tricuspid Regurgitation: Results From the TriValve Registry. [PDF]
OBJECTIVES The purpose of this study was to evaluate procedural and 1-year clinical and echocardiographic outcomes of patients treated with tricuspid edge-to-edge repair.
Brugger, Nicolas +37 more
core +1 more source
Anatomical and Technical Predictors of Three-Dimensional Mitral Valve Area Reduction After Transcatheter Edge-To-Edge Repair. [PDF]
BACKGROUND Among current transcatheter therapies for the treatment of mitral regurgitation, the MitraClip (MC; Abbott Vascular, Abbott Park, IL) system is the most commonly used.
Brugger, Nicolas +6 more
core +1 more source
Transcatheter mitral valve repair for primary mitral regurgitation
The landscape of transcatheter mitral valve repair devices continues to expand, with many technologies undergoing investigation in patients with primary mitral regurgitation (MR).
Rowa H. Attar +2 more
doaj +1 more source

